From: Osteopontin is a prognostic biomarker in non-small cell lung cancer
Parameter | Patients | ||
---|---|---|---|
Number | Percent | ||
Gender | Male | 114 | 54 |
Female | 96 | 46 | |
Histology | Adenocarcinoma (incl. BAC) | 128 | 61 |
Squamous cell carcinoma | 58 | 28 | |
Large cell carcinoma | 24 | 11 | |
Differentiation | G1 (well differentiated) | 20 | 10 |
G2 (moderately differentiated) | 135 | 68 | |
G3 (poorly differentiated) | 43 | 22 | |
Missing | 12 | ||
pTNM | I | 135 | 64 |
II | 43 | 21 | |
III | 32 | 15 | |
pT | pT1 | 67 | 32 |
pT2 | 114 | 54 | |
pT3 | 19 | 9 | |
pT4 | 10 | 5 | |
pN | 0 | 153 | 73 |
1 | 38 | 18 | |
2 | 19 | 9 | |
Tumor size | ≤ 2.0 cm | 56 | 27 |
2.1 – 3.0 cm | 61 | 29 | |
3.1 – 5.0 cm | 64 | 30 | |
5.1 – 7.0 cm | 23 | 11 | |
> 7.0 cm | 6 | 3 | |
Metastasis* | Yes | 55 | 26 |
No | 155 | 74 | |
Local recurrence | Yes | 24 | 11 |
No | 186 | 89 | |
Death | Yes | 70 | 33 |
No | 140 | 67 |